| HEPBsAg | hepatitis B surface antigen |
|---|---|
| HEPES | N-2-hydroxyethylpiperazine-N-2-ethanesulfonic [acid] |
| HEPM | human embryonic palatal mesenchymal [cell] |
| HEPOD | hereditary expansile polyostotic dysplasia |
| hepatoma | hepatocellular carcinoma |
|---|---|
| HepB | Hepatitis B |
| HEPES | N-(2-hydroxyethyl)piperazine-(2-ethanesulfonic acid |
| HepG2 | Hepatoma |
| HepG2 | hepatic |
| HEPT | 1-(2-hydroxyethoxymethyl)-6-(phenylthio)-thymine |
| 영문 | hepatoma | 한글 | 간암 |
|---|---|---|---|
| 설명 | 간세포에서 발생하는 간세포암(hepatoma)과 쓸개관상피세포에서 발생하는 쓸개관암종(cholangiocarcinoma)이 있으며, 드물게 소아에서 발생하는 간모세포종(hepatoblastoma)이 있다. 일반적으로 간암이라고 하면 대부분 간세포에서 기원하는 간세포암종을 말한다. 원인은 대부분이 불분명하지만 간경화가 있는 경우가 많으며, 간경화가 있는 환자와 만성 활동성 B형 간염, 혹은 B형 간염 보균자에서 간암이 잘 생기는 것으로 밝혀져 있다. 증세는 서서히 나타나며, 초기에는 잘 알 수 없으나 식욕부진, 체중감소, 복통 등을 일으킨다. 주로 간이 커져서 우상복부에서 딱딱하게 만져짐으로써 알 수 있는 경우가 많다. 간은 그 크기가 점점 커져서 정상시의 2~3배에 이를 수 있으며, 그 표면이 불규칙한 결절상의 종괴로 울퉁불퉁하다. 간암은 어느 정도 진행하면 급격하게 전신쇠약이 오며, 경과가 매우 빨라서 곧 말기에는 이른다. 말기에 이르면 여러 가지 증세가 나타나는데, 종괴에 의한 쓸갯길의 압박으로 황달이 나타나고, 또 복부 내장의 혈류장애로 복수가 생기기도 한다. 복수는 황색일 때가 많고 때로는 혈액이 혼합되어 있을 때도 있다. 흔히 사용되는 검사로는 간기능검사, B형간염표지자검사, 간 동위원소촬영, 복부초음파검사, 복부컴퓨터단층촬영, 간혈관조영술, 혈증 알파태아단백(α-fetoprotein)과 간 조직검사 등이 있다. |
||
| 영문 | hepatomegaly | 한글 | 간비대 |
|---|---|---|---|
| 설명 | 간이 정상보다 크게 된 상태이며, 여러 가지의 간염, 지방간, 울혈, 간경화, 간암, 쓸개길병, 혈액병, 대사병(축적병)등에서 보는 일이 많다. |
||
| heparin antagonists | Coagulant substances inhibiting the anticoagulant action of heparin. (12 Dec 1998) |
|---|---|
| heparin binding growth factor | <growth factor> Acidic fibroblast growth factor (alpha FGF, HBGF 1) and basic FGF (beta FGF, HBGF 2) are the two founder members of a family of structurally related growth factors for mesodermal or neuroectodermal cells. Synonym: heparin binding growth factor. Acronym: FGF (18 Nov 1997) |
| heparin cofactor II | <chemical> A sulfated plasma protein with the mw of approximately 66kda. The protein is an inhibitor of thrombin in plasma that is activated by dermatan sulfate or heparin. It is a member of the serpin superfamily. Pharmacological action: serine proteinase inhibitors. Chemical name: Heparin cofactor II (12 Dec 1998) |
| heparin complement | The protein component of heparin in blood. (05 Mar 2000) |
| heparin eliminase | <enzyme> An enzyme of the isomerase class that catalyses the eliminative cleavage of polysaccharides containing 1,4-linked d-glucuronate or l-iduronate residues and 1,4-alpha-linked 2-sulfoamino-2-deoxy-6-sulfo-d-glucose residues to give oligosaccharides with terminal 4-deoxy-alpha-d-gluc-4-enuronosyl groups at their non-reducing ends. Chemical name: heparin lyase Registry number: EC 4.2.2.7 (12 Dec 1998) |
| heparin lyase | <enzyme> An enzyme of the isomerase class that catalyses the eliminative cleavage of polysaccharides containing 1,4-linked d-glucuronate or l-iduronate residues and 1,4-alpha-linked 2-sulfoamino-2-deoxy-6-sulfo-d-glucose residues to give oligosaccharides with terminal 4-deoxy-alpha-d-gluc-4-enuronosyl groups at their non-reducing ends. Chemical name: heparin lyase Registry number: EC 4.2.2.7 (12 Dec 1998) |
| heparin unit | The quantity of heparin required to keep 1 ml of cat's blood fluid for 24 hr at 0캜; it is equivalent approximately to 0.002 mg of pure heparin. Synonym: Howell unit. (05 Mar 2000) |
| heparin, low-molecular-weight | <chemical> Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of haemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. Pharmacological action: anticoagulant, fibrinolytic agent. (12 Dec 1998) |
| heparin-glucosamine 3-O-sulfotransferase | <enzyme> Reaction: 3'-phosphoadenylylsulfate + heparin-glucosamine = adenosine 3',5'-bisphosphate + heparin glucosamine 3-o-sulfate Registry number: EC 2.8.2.23 Synonym: glucosaminyl 3-o-sulfotransferase, d-glucosaminyl 3-o-sulfotransferase (26 Jun 1999) |
| heparinaemia | The presence of demonstrable levels of heparin in the circulating blood. (05 Mar 2000) |
| heparinase | <enzyme> An enzyme of the isomerase class that catalyses the eliminative cleavage of polysaccharides containing 1,4-linked d-glucuronate or l-iduronate residues and 1,4-alpha-linked 2-sulfoamino-2-deoxy-6-sulfo-d-glucose residues to give oligosaccharides with terminal 4-deoxy-alpha-d-gluc-4-enuronosyl groups at their non-reducing ends. Chemical name: heparin lyase Registry number: EC 4.2.2.7 (12 Dec 1998) |
| heparinic acid | <drug> Sulphated mucopolysaccharide, found in granules of mast cells, that inhibits the action of thrombin on fibrinogen by potentiating antithrombins, thereby interfering with the blood clotting cascade. Platelet factor IV will neutralise heparin. (18 Nov 1997) |
| heparinise | To perform therapeutic administration of heparin. (05 Mar 2000) |
| heparinoids | <chemical> Heparin derivatives. The term has also been used more loosely to include naturally occurring and synthetic highly-sulphated polysaccharides of similar structure. Heparinoid preparations have been used for a wide range of applications including as anticoagulant and anti-inflammatories and they have been claimed to have hypolipidemic properties. Pharmacological action: anti-inflammatory agents, anticoagulant. (12 Dec 1998) |
| heparitin sulfate | <chemical> Heparitin, sulfate. A glycosaminoglycan occurring in the liver, aorta, and lung. It has a structure similar to heparin, but there are more n-acetyl groups and fewer o- and n-sulfate groups. It is an accumulation product in several mucopolysaccharidoses. Chemical name: Heparitin, sulfate (12 Dec 1998) |
Synonyms : Antagonists, Heparin
Synonyms : Heparin Co-Factor II, Co-Factor II, Heparin, Cofactor II, Heparin, Heparin Co Factor II
Synonyms : Neutralase, Eliminase, Heparin, I, Heparinase, Lyase, Heparin
Synonyms : Low Molecular Weight Heparin, Heparin, Low Molecular Weight
Synonyms : Ateroid, Atheroid, Heparinoid
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
오스파인퓨전주 - 새창
|
한국메디텍 |
A20501011 | Ornithine aspartate | 전문의약품 | 급여 | 분업예외의약품 |
|
중외헤파린나트륨주사액1,000단위 - 새창
|
중외 |
A02104111 | Heparin sodium | 전문의약품 | 급여 | 분업예외의약품 |
|
메디텍헤파린나트륨주사액25,000단위 - 새창
|
한국메디텍 |
A20500531 | Heparin sodium | 전문의약품 | 삭제 | 분업예외의약품 |
|
한림헤파린나트륨주25,000단위 - 새창
|
한림제약 |
A37800521 | Heparin sodium | 전문의약품 | 급여 |
|
중외헤파린주사액 - 새창
|
중외 |
A02101541 | Heparin sodium | 전문의약품 | 급여 | 분업예외의약품 |
|
신풍헤파린나트륨주25,000단위 - 새창
|
신풍제약 |
A00302871 | Heparin sodium | 전문의약품 | 급여 | 분업예외의약품 |
|
선플라주100mg - 새창
|
SK케미칼 |
A18901731 | Heptaplatin | 전문의약품 | 급여 | 분업예외의약품 |
|
선플라주50mg - 새창
|
SK케미칼 |
A18901451 | Heptaplatin | 전문의약품 | 삭제 | 분업예외의약품 |
|
헤파멜즈산 - 새창
|
한화제약 |
A15300951 | L-Ornithine-L-Aspartate | 일반의약품 | 급여 |
|
헤파리겐정100mg - 새창
|
보령제약 |
A09300411 | Timonacic | 일반의약품 | 급여 |
| hepatolenticular degeneration |
a rare inherited disorder of copper metabolism; copper accumulates in the liver and then in the red blood cells and brain
출처: wordnet.princeton.edu/perl/webwn
|
|---|---|
| hepatoma |
carcinoma of the liver
출처: wordnet.princeton.edu/perl/webwn
|
| hepatomegaly |
abnormal enlargement of the liver
출처: wordnet.princeton.edu/perl/webwn
|
| hepatotoxic |
toxic to the liver
출처: wordnet.princeton.edu/perl/webwn
|
| hepatotoxin |
any toxin that affects the liver
출처: wordnet.princeton.edu/perl/webwn
|
| HEP | any of several plants of the genus Hepatica having 3-lobed leaves and white or pinkish flowers in early spring |
|---|---|
| HEP | liverworts: comprises orders Anthocerotales |
| HEP | liverworts: comprises orders Anthocerotales |
| HEP | inflammation of the liver caused by a virus or a toxin |
| HEP | an acute but benign form of viral hepatitis caused by an RNA virus that does not persist in the blood serum and is usually transmitted by ingesting food or drink that is contaiminated with fecal matter |
| HEP | the virus causing hepatitis A |
| HEP | an acute (sometimes fatal) form of viral hepatitis caused by a DNA virus that tends to persist in the blood serum and is transmitted by sexual contact or by transfusion or by ingestion of contaminated blood or other bodily fluids |
| HEP | a viral hepatitis clinically indistinguishable from hepatitis B but caused by a single-stranded RNA virus |
| HEP | a severe form of hepatitis |
| HEP | carcinoma of the liver |
| HEP | carcinoma of the liver |
| HEP | a B vitamin that prevents skin lesions and weight loss |
